These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17130941)

  • 41. The cost effectiveness of rotavirus vaccination in Iran.
    Mousavi Jarrahi Y; Zahraei SM; Sadigh N; Esmaeelpoor Langeroudy K; Khodadost M; Ranjbaran M; Sanjari Moghaddam A; Besharat M; Mosavi Jarrahi A
    Hum Vaccin Immunother; 2016 Mar; 12(3):794-800. PubMed ID: 26360331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: A country-led analysis.
    Diop A; Atherly D; Faye A; Lamine Sall F; Clark AD; Nadiel L; Yade B; Ndiaye M; Fafa Cissé M; Ba M
    Vaccine; 2015 May; 33 Suppl 1():A119-25. PubMed ID: 25919151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan.
    Freiesleben de Blasio B; Flem E; Latipov R; Kuatbaeva A; Kristiansen IS
    Emerg Infect Dis; 2014 Jan; 20(1):29-37. PubMed ID: 24378188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination.
    Shim E; Galvani AP
    Vaccine; 2009 Jun; 27(30):4025-30. PubMed ID: 19389452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness of childhood rotavirus vaccination in Taiwan.
    Wu CL; Yang YC; Huang LM; Chen KT
    Vaccine; 2009 Mar; 27(10):1492-9. PubMed ID: 19186200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia.
    Reyes JF; Wood JG; Beutels P; Macartney K; McIntyre P; Menzies R; Mealing N; Newall AT
    Vaccine; 2017 Jan; 35(2):345-352. PubMed ID: 27916411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031.
    Nonvignon J; Atherly D; Pecenka C; Aikins M; Gazley L; Groman D; Narh CT; Armah G
    Vaccine; 2018 Nov; 36(47):7215-7221. PubMed ID: 29223486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness of Rotavirus vaccination in Vietnam.
    Kim SY; Goldie SJ; Salomon JA
    BMC Public Health; 2009 Jan; 9():29. PubMed ID: 19159483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness estimates of vaccination against rotavirus in Piedmont, Italy.
    Gualano MR; Thomas R; Gili R; Scaioli G; Voglino G; Zotti C
    J Infect Public Health; 2018; 11(6):867-872. PubMed ID: 30078657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemiological and Economic Impact of Monovalent and Pentavalent Rotavirus Vaccines in Low and Middle Income Countries: A Cost-effectiveness Modeling Analysis.
    Paternina-Caicedo A; De la Hoz-Restrepo F; Alvis-Guzmán N
    Pediatr Infect Dis J; 2015 Jul; 34(7):e176-84. PubMed ID: 25923424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan.
    Anwari P; Debellut F; Pecenka C; Parwiz SM; Clark A; Groman D; Safi N
    Vaccine; 2018 Dec; 36(51):7769-7774. PubMed ID: 29107346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted.
    Thomas SL; Walker JL; Fenty J; Atkins KE; Elliot AJ; Hughes HE; Stowe J; Ladhani S; Andrews NJ
    Vaccine; 2017 Jan; 35(4):680-686. PubMed ID: 28007397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Economics of rotavirus gastroenteritis and vaccination in Europe: what makes sense?
    Rheingans RD; Heylen J; Giaquinto C
    Pediatr Infect Dis J; 2006 Jan; 25(1 Suppl):S48-55. PubMed ID: 16397429
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children.
    Chotivitayatarakorn P; Chotivitayatarakorn P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):114-25. PubMed ID: 20578490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis.
    Rose J; Hawthorn RL; Watts B; Singer ME
    BMJ; 2009 Sep; 339():b3653. PubMed ID: 19783581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Socio-economic modelling of rotavirus vaccination in Castilla y Leon, Spain.
    Pérez-Rubio A; Luquero FJ; Eiros Bouza JM; Castrodeza Sanz JJ; Bachiller Luque MR; de Lejarazu RO; Sánchez Porto A
    Infez Med; 2011 Sep; 19(3):166-75. PubMed ID: 22037437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium.
    Bilcke J; Van Damme P; Beutels P
    Med Decis Making; 2009; 29(1):33-50. PubMed ID: 18948433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of geographic and economic heterogeneity on rotavirus diarrhea burden and vaccination impact and cost-effectiveness in the Lao People's Democratic Republic.
    Rheingans R; Anderson JD; Bagamian KH; Pecenka CJ
    Vaccine; 2018 Dec; 36(51):7868-7877. PubMed ID: 30007827
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effectiveness analysis of rotavirus vaccination among Libyan children using a simple economic model.
    Alkoshi S; Maimaiti N; Dahlui M
    Libyan J Med; 2014; 9(1):26236. PubMed ID: 25499622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.